Civic Intelligence

Scleroderma Foundationnew England Inc

EIN 22-2603572 • 501(c)3 • Danvers, MA

Profile

Provide educational and emotional support

300 Rosewood DriveDanvers, MA 01923

www.scleroderma.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on the latest valid filing.

Source year 2023

Liabilities / Revenue

61st percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2023

Net Margin

84th percentile

34%

Higher net margin than 84% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2023

Top Officer Pay

Score unavailable

No value available

No filing with officer rows is available for this organization yet.

Asset Growth

9th percentile

-100%

Faster asset growth than 9% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2022 to 2023

Revenue Growth

6th percentile

-92%

Faster revenue growth than 6% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2022 to 2023

Assets

Down

$0

Down $941,134 (-100%) from 2022

Liabilities

Down

$0

Down $87,782 (-100%) from 2022

Net Assets

Down

$0

Down $853,352 (-100%) from 2022

Revenue

Down

$16,749

Down $199,787 (-92%) from 2022

Expenses

Down

$11,040

Down $152,001 (-93%) from 2022

Net Income

Down

$5,709

Down $47,786 (-89%) from 2022

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$1.0M$500K$0Assets 2010: $599,022Liabilities 2010: $0Net Assets 2010: $599,0222010Assets 2011: $754,745Liabilities 2011: $0Net Assets 2011: $754,7452011Assets 2012: $671,985Liabilities 2012: $96,065Net Assets 2012: $575,9202012Assets 2013: $778,262Liabilities 2013: $155,362Net Assets 2013: $622,9002013Assets 2014: $755,658Liabilities 2014: $111,285Net Assets 2014: $644,3732014Assets 2015: $778,703Liabilities 2015: $112,732Net Assets 2015: $665,9712015Assets 2016: $828,869Liabilities 2016: $159,589Net Assets 2016: $669,2802016Assets 2017: $861,135Liabilities 2017: $153,288Net Assets 2017: $707,8472017Assets 2018: $710,223Liabilities 2018: $72,996Net Assets 2018: $637,2272018Assets 2019: $837,989Liabilities 2019: $108,657Net Assets 2019: $729,3322019Assets 2020: $842,101Liabilities 2020: $98,485Net Assets 2020: $743,6162020Assets 2021: $981,565Liabilities 2021: $90,005Net Assets 2021: $891,5602021Assets 2022: $941,134Liabilities 2022: $87,782Net Assets 2022: $853,3522022Assets 2023: $0Liabilities 2023: $0Net Assets 2023: $02023

Highlighted filing

2023

Assets$0
Liabilities$0
Net Assets$0

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$600K$400K$200K$0-$200KRevenue 2010: $344,258Expenses 2010: $338,119Net Income 2010: $6,1392010Expenses 2011: $144,0512011Expenses 2012: $377,4682012Revenue 2013: $413,924Expenses 2013: $355,473Net Income 2013: $58,4512013Revenue 2014: $316,702Expenses 2014: $302,157Net Income 2014: $14,5452014Revenue 2015: $378,749Expenses 2015: $320,023Net Income 2015: $58,7262015Revenue 2016: $343,809Expenses 2016: $375,381Net Income 2016: -$31,5722016Revenue 2017: $340,772Expenses 2017: $361,234Net Income 2017: -$20,4622017Revenue 2018: $350,335Expenses 2018: $347,506Net Income 2018: $2,8292018Revenue 2019: $352,910Expenses 2019: $320,764Net Income 2019: $32,1462019Revenue 2020: $171,878Expenses 2020: $193,132Net Income 2020: -$21,2542020Revenue 2021: $295,424Expenses 2021: $182,782Net Income 2021: $112,6422021Revenue 2022: $216,536Expenses 2022: $163,041Net Income 2022: $53,4952022Revenue 2023: $16,749Expenses 2023: $11,040Net Income 2023: $5,7092023

Highlighted filing

2023

Revenue$16,749
Expenses$11,040
Net Income$5,709

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2023Detailed filing. Detailed filing data is available for this year.$0.00$0.00$0.00$0.17$0.11$0.06
2022Detailed filing. Detailed filing data is available for this year.$9.41$0.88$8.53$2.17$1.63$0.53
2021Detailed filing. Detailed filing data is available for this year.$9.82$0.90$8.92$2.95$1.83$1.13
2020Detailed filing. Detailed filing data is available for this year.$8.42$0.98$7.44$1.72$1.93$0.21
2019Detailed filing. Detailed filing data is available for this year.$8.38$1.09$7.29$3.53$3.21$0.32
2018Detailed filing. Detailed filing data is available for this year.$7.10$0.73$6.37$3.50$3.48$0.03
2017Detailed filing. Detailed filing data is available for this year.$8.61$1.53$7.08$3.41$3.61$0.20
2016Detailed filing. Detailed filing data is available for this year.$8.29$1.60$6.69$3.44$3.75$0.32
2015Detailed filing. Detailed filing data is available for this year.$7.79$1.13$6.66$3.79$3.20$0.59
2014Detailed filing. Detailed filing data is available for this year.$7.56$1.11$6.44$3.17$3.02$0.15
2013Detailed filing. Detailed filing data is available for this year.$7.78$1.55$6.23$4.14$3.55$0.58
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.72$0.96$5.76$3.77
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$7.55$0.00$7.55$1.44
2010Summary only. Only limited summary data is available for this year.$5.99$0.00$5.99$3.44$3.38$0.06
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2023 to Dec 31, 2023
Signed
Jul 9, 2024
Return Version
2023v5.1
Gross Receipts
$21,749
Mission and Program Overview

Mission

Provide educational and emotional support to people with scleroderma and their families; to stimulate and support research designed to identify the cause and cure of scleroderma; and to

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$572,086--
Cash and Non-Interest-Bearing Accounts$335,598--
Pledges and Grants Receivable$21,309--
Prepaid Expenses and Deferred Charges$6,258--
Savings and Temporary Cash Investments$5,005--
Land, Buildings, and Equipment, Net$878--
Total Assets$941,134$0▼ $941,134
Liabilities
Grants Payable$55,812--
Other Liabilities$25,000$0▼ $25,000
Accounts Payable and Accrued Expenses$5,258--
Deferred Revenue$1,712--
Total Liabilities$87,782$0▼ $87,782
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$452,893--
Net Assets With Donor Restrictions$400,459--
Total Net Assets Fund Balance$853,352$0▼ $853,352
Total Liabilities and Net Assets / Fund Balance$941,134$0▼ $941,134

Endowment Activity

PeriodBeginningContrib.Gain/LossOther UsesEnd
2023$395,454---$0
2022$448,725-▼ $53,271-$395,454
2021$426,914-▲ $42,018-$448,725
2020$414,096-▲ $32,538-$426,914
2019$371,451-▲ $61,345-$414,096
Compensation and Service Providers

Board Members and Trustees

NameTitle
Jane LadasPresident
Andrea MahoneyVice President
Anthony CappellucciDirector
Carla KingDirector
David RosenbergDirector
Elysia CappellucciDirector
Scott WinslowDirector
Zak KarsanDirector
Revenue and Support

Revenue Composition

Contributions and Grants
$14,357
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$2,392
All Other Contributions
$14,357
Change in Net Assets
$5,709
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$11,040
Total Fundraising Expense$2,836
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Occupancy$1,964$1,473$1,473$4,910
Office Expenses$1,239$930$930$3,099
Other Expenses$577$433$433$1,443
Depreciation Depletion$0$878$0$878
Fees for Services Accounting$0$710$0$710
Total Functional Expenses$3,780$4,424$2,836$11,040
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Gross Income$7,392
Fundraising Direct Expenses$5,000
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Accrued Affiliate Support$0
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No
Filing and Contact Details

Filer

Filer Name
Scleroderma Foundationnew England Inc
EIN
22-2603572
Phone
9786241254
Address
300 ROSEWOOD DRIVE, DANVERS, MA 01923

Signing Officer

Name
Jane Ladas
Title
President
Phone
9786241254
Signed
2024-07-09
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Anne Sweeney
Formed
1985
Legal Domicile
Ma
Voting Board Members
8
Independent Board Members
8
Employees
0
Volunteers
0

Preparer

Firm
Bernard Johnson & Company Pc
Address
15 MAIN STREET, TOPSFIELD, MA 01983
Preparer
Julie A Couto CPA
Phone
9788872220
Supplemental Narrative

Additional Explanations

Pt VI, Line 11B

The board of directors are provided a draft copy of the federal form 990 prior to finalization. The form 990 is reviewed and approved by the board treasurer. The preparer of the form 990 is notified the return has been approved and may be finalized.

Pt VI, Line 12C

Board members, committee members and employees are required annually to disclose actual or potential conflicts of interest. Identified conflicts are resolved by action of the board president

Pt VI, Line 15A

The executive director is hired through a rigorous board approval process.

Pt XI

The organization merged with national schleroderma foundation and transferred their cash and investments totalling 885,837 to the non profit

Raw XML AppendixShowing 400 of 494 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt05258
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0PROVIDE EDUCATIONAL AND EMOTIONAL SUPPORT TO PEOPLE WITH SCLERODERMA AND THEIR FAMILIES; TO STIMULATE AND SUPPORT RESEARCH DESIGNED TO IDENTIFY THE CAUSE AND CURE OF SCLERODERMA; AND TO
IRS990/AllOtherContributionsAmt014357
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0ANNE SWEENEY
IRS990/BooksInCareOfDetail/PhoneNum09786241254
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0300 ROSEWOOD DRIVE SUITE 105
IRS990/BooksInCareOfDetail/USAddress/CityNm0DANVERS
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd001923
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0335598
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0true
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt014357
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt011040
IRS990/CYOtherRevenueAmt02392
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt05709
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt011040
IRS990/CYTotalFundraisingExpenseAmt02836
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt016749
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DeferredRevenueGrp/BOYAmt01712
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/FundraisingAmt00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt0878
IRS990/DepreciationDepletionGrp/ProgramServicesAmt00
IRS990/DepreciationDepletionGrp/TotalAmt0878
IRS990/Desc0PROVIDE COUNSELING TO PATIENTS AND FAMILY MEMBERS WITH SCLERODERMA. ADDITIONALLY THE ORGANIZATION DONATES FUNDS TO THE NATIONAL SCLERODERMA FOUNDATION TO FUND RESEARCH.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt0400459
IRS990/DonorRstrOrQuasiEndowmentsInd0true
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt03780
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/FundraisingAmt00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt0710
IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt00
IRS990/FeesForServicesAccountingGrp/TotalAmt0710
IRS990/FinalReturnInd0X
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt010.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/PersonNm0JANE LADAS
IRS990/Form990PartVIISectionAGrp/PersonNm1ANDREA MAHONEY
IRS990/Form990PartVIISectionAGrp/PersonNm2ANTHONY CAPPELLUCCI
IRS990/Form990PartVIISectionAGrp/PersonNm3ELYSIA CAPPELLUCCI
IRS990/Form990PartVIISectionAGrp/PersonNm4ZAK KARSAN
IRS990/Form990PartVIISectionAGrp/PersonNm5SCOTT WINSLOW
IRS990/Form990PartVIISectionAGrp/PersonNm6CARLA KING
IRS990/Form990PartVIISectionAGrp/PersonNm7DAVID ROSENBERG
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1VICE PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr01985
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/FundraisingDirectExpensesAmt05000
IRS990/FundraisingGrossIncomeAmt07392
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt08
IRS990/GrantAmt00
IRS990/GrantsPayableGrp/BOYAmt055812
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt021749
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt08
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsPubTradedSecGrp/BOYAmt0572086
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipBasisNetGrp/BOYAmt0878
IRS990/LegalDomicileStateCd0MA
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0PROVIDE EDUCATIONAL AND EMOTIONAL SUPPORT TO PEOPLE WITH SCLERODERMA AND THEIR FAMILIES; TO STIMULATE AND SUPPORT RESEARCH DESIGNED TO IDENTIFY THE CAUSE AND CURE OF SCLERODERMA; AND TO
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt0853352
IRS990/NetAssetsOrFundBalancesEOYAmt00
IRS990/NetIncmFromFundraisingEvtGrp/ExclusionAmt02392
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt02392
IRS990/NetIncmFromFundraisingEvtGrp/UnrelatedBusinessRevenueAmt00
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt0452893
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OccupancyGrp/FundraisingAmt01473
IRS990/OccupancyGrp/ManagementAndGeneralAmt01473
IRS990/OccupancyGrp/ProgramServicesAmt01964
IRS990/OccupancyGrp/TotalAmt04910
IRS990/OfficeExpensesGrp/FundraisingAmt0930
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0930
IRS990/OfficeExpensesGrp/ProgramServicesAmt01239
IRS990/OfficeExpensesGrp/TotalAmt03099
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt0-885837
IRS990/OtherExpensesGrp/Desc0PRINTING AND POSTAGE
IRS990/OtherExpensesGrp/FundraisingAmt0433
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt0433
IRS990/OtherExpensesGrp/ProgramServicesAmt0577
IRS990/OtherExpensesGrp/TotalAmt01443
IRS990/OtherLiabilitiesGrp/BOYAmt025000
IRS990/OtherLiabilitiesGrp/EOYAmt00
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd0false
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt021309
IRS990/PoliticalCampaignActyInd0false
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt06258
IRS990/PrincipalOfficerNm0ANNE SWEENEY
IRS990/PriorPeriodAdjustmentsAmt026776
IRS990/ProfessionalFundraisingInd0false
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt054472
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt015445
IRS990/PYOtherExpensesAmt068749
IRS990/PYOtherRevenueAmt0146619
IRS990/PYRevenuesLessExpensesAmt053495
IRS990/PYSalariesCompEmpBnftPaidAmt094292
IRS990/PYTotalExpensesAmt0163041
IRS990/PYTotalRevenueAmt0216536
IRS990/QuidProQuoContributionsInd0true
IRS990/QuidProQuoContriDisclInd0true
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReconcilationRevenueExpnssAmt05709
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0true
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0false
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0true
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RevenueAmt016749
IRS990/SavingsAndTempCashInvstGrp/BOYAmt05005
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt00
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt014357
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt054472
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt0182147
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt091749
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt072285
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0415010
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt00
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt015445
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt032946
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt016054
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt028464
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt092909
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt07392
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt0215382
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt024806
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt064475
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt0324171
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0636226
IRS990ScheduleA/GrossReceiptsNonUnrltBusGrp/TotalAmt00
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt00
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt015445
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt032946
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt016054
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt028464
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt092909
IRS990ScheduleA/InvestmentIncomeCYPct00.08120
IRS990ScheduleA/InvestmentIncomePYPct00.07940
IRS990ScheduleA/OtherSupportSumAmt00
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00
IRS990ScheduleA/PublicSupportCY509Pct00.91880
IRS990ScheduleA/PublicSupportPY509Pct00.92060
IRS990ScheduleA/PublicSupportTotal509Amt01051236
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/TotalAmt00
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft509Grp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt021749
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0269854
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0206953
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0156224
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0396456
IRS990ScheduleA/Total509Grp/TotalAmt01051236
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt01144145
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/CYEndwmtFundGrp/BeginningYearBalanceAmt0395454
IRS990ScheduleD/CYEndwmtFundGrp/EndYearBalanceAmt00
IRS990ScheduleD/CYEndwmtFundGrp/GrantsOrScholarshipsAmt0395454
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/BeginningYearBalanceAmt0448725
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/EndYearBalanceAmt0395454
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/GrantsOrScholarshipsAmt00
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/InvestmentEarningsOrLossesAmt0-53271
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/BeginningYearBalanceAmt0426914
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/EndYearBalanceAmt0448725
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/GrantsOrScholarshipsAmt020207
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/InvestmentEarningsOrLossesAmt042018
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/BeginningYearBalanceAmt0414096
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/EndYearBalanceAmt0426914
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/GrantsOrScholarshipsAmt019720
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/InvestmentEarningsOrLossesAmt032538
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/BeginningYearBalanceAmt0371451
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/EndYearBalanceAmt0414096
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/GrantsOrScholarshipsAmt018700
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/InvestmentEarningsOrLossesAmt061345
IRS990ScheduleD/EndowmentsHeldRelatedOrgInd0false
IRS990ScheduleD/EndowmentsHeldUnrelatedOrgInd0false
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt00
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0ACCRUED AFFILIATE SUPPORT
IRS990ScheduleD/TotalLiabilityAmt00
IRS990/ScheduleJRequiredInd0false
IRS990ScheduleN/AssetsDistributedInd0true
IRS990ScheduleN/AttorneyGeneralNotifiedInd0true
IRS990ScheduleN/BondsOutstandingInd0false
IRS990ScheduleN/DirectorOfSuccessorInd0true
IRS990ScheduleN/EmployeeOfSuccessorInd0true
IRS990ScheduleN/LiabilitiesPaidInd0true
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/AssetsDistriOrExpnssPaidDesc0CHARLES SCHWAB INVESTMENT A/C
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/AssetsDistriOrExpnssPaidDesc1CHARLES SCHWAB INVESTMENT A/C
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/AssetsDistriOrExpnssPaidDesc2CASH CAMBRIDGE SAVINGS BANK
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/AssetsDistriOrExpnssPaidDesc3CASH PEOPLES UNITED BANK
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/AssetsDistriOrExpnssPaidDesc4CASH PEOPLES UNITED BANK
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/AssetsDistriOrExpnssPaidDesc5CASH CAMBRIDGE SAVINGS BANK
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/BusinessName/BusinessNameLine1Txt0NATIONAL SCLERODERMA FOUNDATION
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/BusinessName/BusinessNameLine1Txt1NATIONAL SCLERODERMA FOUNDATION
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/BusinessName/BusinessNameLine1Txt2NATIONAL SCLERODERMA FOUNDATION
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/BusinessName/BusinessNameLine1Txt3NATIONAL SCLERODERMA FOUNDATION
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/BusinessName/BusinessNameLine1Txt4NATIONAL SCLERODERMA FOUNDATION
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/DistributionDt02023-01-01
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/DistributionDt12023-01-01
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/DistributionDt22023-03-21
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/DistributionDt32023-03-21
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/DistributionDt42023-06-14
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/DistributionDt52023-06-23
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/EIN0521375827
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/EIN1521375827
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/EIN2521375827
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/EIN3521375827
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/EIN4521375827
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/EIN5521375827
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/FairMarketValueOfAssetAmt0395455
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/FairMarketValueOfAssetAmt1176633
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/FairMarketValueOfAssetAmt2189170
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/FairMarketValueOfAssetAmt3108353
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/FairMarketValueOfAssetAmt45939
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/FairMarketValueOfAssetAmt510287
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/IRCSectionTxt0501 (C) (3)
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/IRCSectionTxt1501 (C) (3)
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/IRCSectionTxt2501 (C) (3)
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/IRCSectionTxt3501 (C) (3)
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/IRCSectionTxt4501 (C) (3)
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/IRCSectionTxt5501 (C) (3)
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/MethodOfFMVDeterminationTxt0NYSE
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/MethodOfFMVDeterminationTxt1NYSE
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/MethodOfFMVDeterminationTxt2CASH TRANSFERRED
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/MethodOfFMVDeterminationTxt3CASH TRANSFERRED
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/MethodOfFMVDeterminationTxt4STATEMENT BALANCE
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/MethodOfFMVDeterminationTxt5STATEMENT BALANCE
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/PersonNm0NATIONAL SCLERODERMA FOUNDATION
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/AddressLine1Txt0300 ROSEWOOD DRIVE SUITE 105
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/AddressLine1Txt1300 ROSEWOOD DRIVE SUITE 105
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/AddressLine1Txt2300 ROSEWOOD DRIVE SUITE 105
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/AddressLine1Txt3300 ROSEWOOD DRIVE SUITE 105
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/AddressLine1Txt4300 ROSEWOOD DRIVE SUITE 105
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/AddressLine1Txt5300 ROSEWOOD DRIVE SUITE 105
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/CityNm0DANVERS
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/CityNm1DANVERS
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/CityNm2DANVERS
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/CityNm3DANVERS
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/CityNm4DANVERS
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/CityNm5DANVERS
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/StateAbbreviationCd0MA
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/StateAbbreviationCd1MA
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/StateAbbreviationCd2MA
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/StateAbbreviationCd3MA
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/StateAbbreviationCd4MA
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/StateAbbreviationCd5MA
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/ZIPCd001923
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/ZIPCd101923
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/ZIPCd201923
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/ZIPCd301923
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/ZIPCd401923
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/ZIPCd501923
IRS990ScheduleN/OwnerOfSuccessorInd0false
IRS990ScheduleN/ReceiveCompensationInd0false
IRS990ScheduleN/RequiredToNotifyAGInd0true
IRS990ScheduleN/SupplementalInformationDetail/ExplanationTxt0The only employee for SFNE became an employee of the National Scleroderma Foundation as of January 1, 2023 and the Board President Jane Ladas became a board member of National Scleroderma Foundation
IRS990ScheduleN/SupplementalInformationDetail/FormAndLineReferenceDesc0Part I, Line 2e
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE BOARD OF DIRECTORS ARE PROVIDED A DRAFT COPY OF THE FEDERAL FORM 990 PRIOR TO FINALIZATION. THE FORM 990 IS REVIEWED AND APPROVED BY THE BOARD TREASURER. THE PREPARER OF THE FORM 990 IS NOTIFIED THE RETURN HAS BEEN APPROVED AND MAY BE FINALIZED.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1BOARD MEMBERS, COMMITTEE MEMBERS AND EMPLOYEES ARE REQUIRED ANNUALLY TO DISCLOSE ACTUAL OR POTENTIAL CONFLICTS OF INTEREST. IDENTIFIED CONFLICTS ARE RESOLVED BY ACTION OF THE BOARD PRESIDENT
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2THE EXECUTIVE DIRECTOR IS HIRED THROUGH A RIGOROUS BOARD APPROVAL PROCESS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE ORGANIZATION MERGED WITH NATIONAL SCHLERODERMA FOUNDATION AND TRANSFERRED THEIR CASH AND INVESTMENTS TOTALLING 885,837 TO THE NON PROFIT
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Pt VI, Line 11b
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Pt VI, Line 12c
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Pt VI, Line 15a
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Pt XI
IRS990ScheduleR/AssetExchangeInd0false
IRS990ScheduleR/AssetPurchaseFromOtherOrgInd0false
IRS990ScheduleR/AssetSaleToOtherOrgInd0false
IRS990ScheduleR/DivRelatedOrganizationInd0false
IRS990ScheduleR/GiftGrntCapContriFromOthOrgInd0false
IRS990ScheduleR/GiftGrntOrCapContriToOthOrgInd0false
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/ControlledOrganizationInd0false
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/DirectControllingEntityName/BusinessNameLine1Txt0NA
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/DisregardedEntityName/BusinessNameLine1Txt0SCLERODERMA FOUNDATION INC
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/EIN0521375827
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/ExemptCodeSectionTxt0501(C)(3)
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/LegalDomicileStateCd0MA
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/PrimaryActivitiesTxt0SCLERODERMA RESEARCH
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/PublicCharityStatusTxt09
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/AddressLine1Txt0300 ROSEWOOD DRIVE SUITE 105

Document Assets

No mirrored PDF or thumbnail assets are attached yet.